Navigation Links
Rare Cancer- Subject of Study

Physicians at Wake Forest University Baptist Medical Center have developed new techniques that assist in the easy diagnosis of rare cancers. They published the results// of their study in the American Journal of Surgical Pathology. Robert F. Bradley, M.D said that tumors of the appendix that have metastasized through the abdominal cavity are all referred to as cancer. Bradley, a pathology resident, and colleagues studied 101 patients with pseudomyxoma peritonei, a rare form of cancer of the lining of the abdominal cavity. The cancer produces mucin, a jelly-like substance begins in the appendix or colon and spreads to the abdominal lining.

Wake Forest is one of a few centers in the country that offers surgery to remove the tumor and then infusion of heated chemotherapy drugs into the abdominal cavity. This type of cancer is rare and the treatment includes removal of appendices. After this the sections of the tumor are studied and classified it into three general categories: high-grade cancer, low-grade cancer, and benign. But patients in all the three groups are subjected to the same treatment. The classification is mainly to indicate the type of response generated by the patient. Patients from 1993 to 2005 were treated and found one-year, three-year and five-year survival rates were not significantly different for patients in the low-grade cancer and benign categories.

But those in the high-grade category had significantly worse survival. It is seen that there is no separate benign category but physicians should expect it to behave like low-grade cancer. If it is properly treated then it has a favorable prognosis. In conclusion he said that surgery plus abdominal chemotherapy known as intraperitoneal hyperthermic chemotherapy (IPHC) together is used in the treatment of tumors that had spread from the appendix, small bowels, ovaries, colon, rectum and stomach has improved the overall survival and quality of life.

Page: 1

Related medicine news :

1. Protein acts as "Master Switch" that cuts off cells Cancer-Growth machinery
2. Cancer-causing Property Of Teflon Leaves US Regulators Concerned
3. Now A Cancer-Fighting Tomato
4. Cancer-Causing Virus Synthesizes Protein To Help Sustain Itself In Host Cells
5. New Cancer-Blocking Algae Found
6. Cancer-Killing Compound From A Fungus
7. Cancer-Killing Viruses Employ Multiple Mechanisms
8. Arimidex-Herceptin Combo Therapy For Breast Cancer-Clinical Trial Findings
9. Head and Neck Cancer-Taxotere Approved
10. Common Virus Enhances Cancer-Fighting Ability of Standard Chemotherapy Drugs
11. Genes That Allow Brain Cancer-Causing Stem Cells to Resist Treatment Identified
Post Your Comments:

(Date:11/30/2015)... ... November 30, 2015 , ... ... states in the U.S. require dental technicians to be certified or obtain continuing ... NADL created the “What’s In Your Mouth?” campaign to inform dentists that the ...
(Date:11/30/2015)... Los Angeles, CA (PRWEB) , ... November 30, 2015 , ... ... such as grafts, strip harvesting and follicular unit extraction. These techniques and procedures have ... of helping patients suffering from hair loss. While Dr. Parsa Mohebi, M.D. has utilized ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... its annual fundraising campaign to raise funds for its research, education, support, and ... of the organization’s annual funding. , The Mesothelioma Applied Research Foundation, which also ...
(Date:11/30/2015)... ... , ... Cycling, running, and walking are regular Sunday activities for many South ... 28, 2016. , That’s when the 7th annual ANF Group Tour de Broward ... and families at Joe DiMaggio Children’s Hospital. , The community fundraiser, sponsored ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... athletic teams looking to maximize recovery through quality sleep. Tim DiFrancesco, training coach ... get a better night’s sleep. ChiliPad precisely regulates the surface temperature of each ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Nov. 30, 2015 Baxalta Incorporated ... leader dedicated to delivering transformative therapies to ... conditions, today announced the launch and first ... an extended circulating half-life recombinant factor VIII ... full-length ADVATE [Antihemophilic Factor (Recombinant)]. The treatment ...
(Date:11/30/2015)... 2015 (HK$,000)For the Six Months Ended 30 September 2015 2014RestatedChange%Turnover 545,575 ... 421,979 , 384,242 , 9.8 ... 34,719 , (18.3) Medical Insurance Administration Service Income ... 16.1 Medical Devices and Accessories Sales , 89,645 ... Medicines Sales , 2,822 , 2,917 ...
(Date:11/30/2015)... , November 30, 2015 --> ... report "Dental Lasers Market by Product (Soft Tissue, All Tissue, ... User (Hospitals, Clinics), and Geography - Global Forecast to 2020", ... by 2020, at a CAGR of 5.2% during the forecast ... market data Tables and 62 Figures spread through 167 P ...
Breaking Medicine Technology: